Skip to Main Content
Douglas Strand, Ph.D.

Douglas Strand, Ph.D.

Associate Professor

School
Medical School
Department
Urology | Green Ctr for Reprod Bio Scncs
Graduate Programs
Cancer Biology, Genetics, Development and Disease
  • Biography

    Download Curriculum Vitae

    Dr. Strand completed his PhD in the laboratory of David Rowley, PhD in the department of Molecular and Cellular Biology at Baylor College of Medicine. There he worked on the molecular mechanisms regulating reactive stroma in prostate cancer. From there Dr. Strand moved on to the laboratory of Simon Hayward, PhD in the Urology department at Vanderbilt University to perform his post-doctoral training. It was here that Dr. Strand developed an interest in solving the cellular and molecular pathogenesis of benign prostatic hyperplasia and lower urinary tract dysfunction. In 2014, Dr. Strand joined with Claus Roehrborn, MD, chair of the Urology department at UT Southwestern and a world-renowned expert in BPH/LUTS treatment. Dr. Strand has developed an unparalleled human tissue biorepository that is used for his translational research program that uses single cell and spatial transcriptomic approaches. He is a member of the GenitoUrinary Development Molecular Atlas Program (GUDMAP), the Human Cell Atlas (HCA), the Chan Zuckerberg Initiative (CZI), and the HUman BioMolecular Atlas Program (HUBMAP). 

  • Education
    Undergraduate
    Liberty University (2001), Biology
    Graduate School
    Baylor College of Medicine (2007), Molecular & Cell Biology
  • Research Interest
    • Benign Prostatic Hyperplasia
    • bladder cancer
    • detrusor dysfunction
    • Prostate Cancer
  • Publications

    Star Featured Publications

    Featured Featured Featured Featured Featured
    PSA density is associated with BPH cellular composition.
    Jia L, Strand DW, Goueli RS, Gahan JC, Roehrborn CG, Mauck RJ, Prostate 2022 Jun
    Magnetic Resonance Imaging Features Associated with Histology of Benign Prostatic Hyperplasia Nodules: Generation of a Predictive Model.
    Dai JC, Morgan TN, Goueli R, Parrott D, Kenigsberg A, Mauck RJ, Roehrborn C, Strand DW, Costa DN, Gahan JC, J Endourol 2021 Sep
    Targeting phenotypic heterogeneity in benign prostatic hyperplasia.
    Strand DW, Costa DN, Francis F, Ricke WA, Roehrborn CG Differentiation 2017 Aug 96 49-61
    Molecular pathogenesis of human prostate basal cell hyperplasia.
    Henry G, Malewska A, Mauck R, Gahan J, Hutchinson R, Torrealba J, Francis F, Roehrborn C, Strand D Prostate 2017 Aug
  • Books

    Featured 

  • Honors & Awards
    • AUA Travel Award
      (2013)
    • K01DK098277
      Mentored training grant on the role of metabolism in prostate differentiation and disease (2013-2018)
    • StarBrite VICTR award
      Pilot funding to study the role of inflammation in BPH progression (2013-2014)
    • NIH LRP award
      Loan repayment program award (2010-2012)
    • StarBrite VICTR award
      Pilot funding to study the role of lipid metabolism in prostate cancer (2010-2011)
    • DoD Postdoctoral Training Award
      2 year fellowship to study the role of stomal-epithelial interactions in prostate cancer progression (2009-2011)
    • SBUR travel award
      (2006)
  • Professional Associations/Affiliations
    • American Urological Association (2014)
    • GUDMAP (2018)
    • HCA (2020)
    • HUBMAP (2020)
    • SOBPD (2021)
    • Society for Basic Urologic Research (2009)